Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Join us for Meetings in Minutes – AHA Scientific Sessions 2010 – Day 3. Our third daily wrap-up features highlights from the key late breaking trials, and some…
Join us for Meetings in Minutes – AHA Scientific Sessions 2010 – Day 2. Our second daily wrap-up features highlights from the key late breaking trials, and some…
Join us for Meetings in Minutes – AHA Scientific Sessions 2010 – Day 1. Our first day wrap-up features highlights from the presidential address, the key late breaking…
Did you miss AMA’s 2010 Interim Meeting of the House of Delegates? Don’t worry, The Doctor’s Channel has you covered. Get all of the highlights from the meeting…
NEW YORK (Reuters Health) – Compared with zoledronic acid, the monoclonal antibody denosumab is more effective in delaying skeletal-related events in women with breast cancer that has metastasized…
The Doctor’s Channel is on location in Chicago at the American Heart Association Scientific Sessions 2010. We will be bringing you need-to-know information on late breaking trials, scientific…
NEW YORK (Reuters Health) – The tyrosine kinase inhibitors gefitinib or erlotinib may slow the development of central nervous system metastases in patients with advanced non-small cell lung…
“Minutes in Minutes” Rapid Daily Meeting Highlights for Monday, November 10, 2010 Not able to attend the AMA’s 2010 Interim Meeting of the House of Delegates? Catch our…
“Minutes in Minutes” Rapid Daily Meeting Highlights for Sunday, November 7, 2010 Not able to attend the AMA’s 2010 Interim Meeting of the House of Delegates? Catch our…
“Minutes in Minutes” Rapid Daily Meeting Highlights for Saturday, November 6, 2010 Not able to attend the AMA’s 2010 Interim Meeting of the House of Delegates? Catch our…
